دورية أكاديمية

Severe Coronary Vasospasms in Asymptomatic COVID-19.

التفاصيل البيبلوغرافية
العنوان: Severe Coronary Vasospasms in Asymptomatic COVID-19.
المؤلفون: Masarweh OM; Internal Medicine, University of Central Florida, Orlando, USA., Gonzalez-Morales U; Internal Medicine, University of Central Florida, Orlando, USA., Tahir S; Physiology, University of Florida, Gainseville, USA., Tahir S; College of Science, University of Central Florida, Orlando, USA., Hussain ST; Cardiology, Heart and Vascular Institute, Osceola Regional Medical Center/University of Central Florida College of Medicine, Kissimmee, USA.
المصدر: Cureus [Cureus] 2024 Jul 18; Vol. 16 (7), pp. e64869. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019, we have witnessed its multi-organ system involvement, not limiting itself to the lungs. We present a case of a patient with asymptomatic coronavirus disease 2019 (COVID-19) infection who developed ST-elevation myocardial infarction (STEMI) due to coronary artery vasospasm. The patient exhibited symptoms of acute coronary syndrome, elevated troponins, and electrocardiographic changes consistent with STEMI. He was found to have significant coronary vasospasm on angiography that responded well to nitroglycerin. This case highlights the potential cardiovascular complications of COVID-19 infection, even when asymptomatic, and the importance of considering vasospasm as a possible mechanism in patients presenting with acute coronary syndrome. We also elaborate on some potential pathophysiological mechanisms in which COVID-19 may lead to coronary vasospasm.
Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. HCA and UCF issued approval MS1216. This case report was approved for publishing by the HCA research advisory committee as well as HCA PubClear in which supporting documents including authorship consent forms and patient consent were signed. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
(Copyright © 2024, Masarweh et al.)
References: Circulation. 2020 Jun 9;141(23):1903-1914. (PMID: 32297796)
J Cardiol Cases. 2023 May 24;:. (PMID: 37361644)
N Engl J Med. 2020 Jun 18;382(25):2478-2480. (PMID: 32302081)
JACC Basic Transl Sci. 2020 Apr 10;5(5):537-542. (PMID: 32292847)
Lancet. 2020 Mar 28;395(10229):1033-1034. (PMID: 32192578)
فهرسة مساهمة: Keywords: cardiology; coronary artery vasospasm; covid 19; left heart catheterization; st-elevation myocardial infarction (stemi)
تواريخ الأحداث: Date Created: 20240819 Latest Revision: 20240820
رمز التحديث: 20240820
مُعرف محوري في PubMed: PMC11330375
DOI: 10.7759/cureus.64869
PMID: 39156367
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.64869